semaglutide side effects vision loss Ozempic Lawsuit Could Ozempic and Wegovy Be

Doctors may prescribe it for adults with obesity (a BMI of 30 or higher) or those who are overweight (a BMI of 27 or higher) and have other medical conditions such as diabetes, hypertension, and hypercholesterolemia

Preclinical models show that GLP-1 agonists can reduce neuroinflammation by dampening microglial activation and decreasing pro-inflammatory cytokines, suggesting potential applications in protecting against neurodegenerative diseases like Alzheimer's and Parkinson's disease

They differ in absorption rate and dosing convenience

In Wegovys clinical trials, hair loss was reported in 3% of participants compared to 1% on placebo